Cargando…

Better HbA1c during the first years after diagnosis of type 1 diabetes is associated with residual C peptide 10 years later

OBJECTIVE: To identify the factors associated with residual C peptide production at least 10 years after diagnosis in children and adolescents with type 1 diabetes. RESEARCH DESIGN AND METHODS: 73 children and adolescents (<25 years), born in 1988–2005, diagnosed with type 1 diabetes were include...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grönberg, Annika, Espes, Daniel, Carlsson, Per-Ola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Clinical Care/Education/Nutrition
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206906/ https://www.ncbi.nlm.nih.gov/pubmed/32107263 http://dx.doi.org/10.1136/bmjdrc-2019-000819

Ejemplares similares

Higher risk of severe hypoglycemia in children and adolescents with a rapid loss of C-peptide during the first 6 years after type 1 diabetes diagnosis
por: Grönberg, Annika, et al.
Publicado: (2022)

Validation and feasibility of a postal system for remote monitoring of HbA1c
por: Cross, Jen, et al.
Publicado: (2021)

HbA1c response and hospital admissions following commencement of flash glucose monitoring in adults with type 1 diabetes
por: Stimson, Roland H, et al.
Publicado: (2020)

Effect of regular exercise training on changes in HbA1c, BMI and VO(2)max among patients with type 2 diabetes mellitus: an 8-year trial
por: Najafipour, Farzad, et al.
Publicado: (2017)

Inpatient HbA1c testing: a prospective observational study
por: Nanayakkara, Natalie, et al.
Publicado: (2015)

HbA(1c) and the Prediction of Type 2 Diabetes in Children and Adults
por: Vijayakumar, Pavithra, et al.
Publicado: (2017)

Fall in C-Peptide During First 4 Years From Diagnosis of Type 1 Diabetes: Variable Relation to Age, HbA(1c), and Insulin Dose
por: Hao, Wei, et al.
Publicado: (2016)

HbA1c reduction following flash monitoring commencement is not independently associated with adverse diabetic eye disease outcomes in type 1 diabetes
por: Al-Dalla Ali, Muhammad, et al.
Publicado: (2020)

Performance of HbA(1c) and Fasting Plasma Glucose in Screening for Diabetes in Patients Undergoing Coronary Angiography
por: Wang, Jun-Sing, et al.
Publicado: (2013)

Variables associated with HbA1c and weight reductions when adding liraglutide to multiple daily insulin injections in persons with type 2 diabetes (MDI Liraglutide trial 3)
por: Dahlqvist, Sofia, et al.
Publicado: (2018)

HbA1c performs well in monitoring glucose control even in populations with high prevalence of medical conditions that may alter its reliability: the OPTIMAL observational multicenter study
por: Niwaha, Anxious J, et al.
Publicado: (2021)

Good glycemic control without exceeding the BMI trajectory during the first 5 years of treatment in children and adolescents with type 1 diabetes
por: Grönberg, Annika, et al.
Publicado: (2022)

HbA(1c): The lower the better?
por: Araki, Eiichi, et al.
Publicado: (2011)

Diabetes case finding in the emergency department, using HbA1c: an opportunity to improve diabetes detection, prevention, and care
por: Hng, Tien-Ming, et al.
Publicado: (2016)

Integrative health coaching: a behavior skills approach that improves HbA1c and pharmacy claims-derived medication adherence
por: Wolever, Ruth Q, et al.
Publicado: (2016)

Real-life data of hypoglycemic events in children and adolescents with type 1 diabetes
por: Hill, Henrik, et al.
Publicado: (2023)

HbA(1c) After a Short Period of Monotherapy With Metformin Identifies Durable Glycemic Control Among Adolescents With Type 2 Diabetes
por: Zeitler, Phil, et al.
Publicado: (2015)

Glucose Regulation Beyond HbA(1c) in Type 2 Diabetes Treated With Insulin: Real-World Evidence From the DIALECT-2 Cohort
por: den Braber, Niala, et al.
Publicado: (2021)

Effect of baseline HbA1c level on the development of diabetes by lifestyle intervention in primary healthcare settings: insights from subanalysis of the Japan Diabetes Prevention Program
por: Sakane, Naoki, et al.
Publicado: (2014)

HbA(1c) Reduction in Dulaglutide-Treated Patients Irrespective of Duration of Diabetes, Microvascular Disease, and BMI: A Post Hoc Analysis From the REWIND Trial
por: Kwan, Anita Y.M., et al.
Publicado: (2022)

Recovery of premorbid BMI trajectory without overshoot during the first year of treatment of children with type 1 diabetes
por: Grönberg, Annika, et al.
Publicado: (2016)

The Adaptation of the Carbohydrate Counting Method Affects HbA1c and Improves Anthropometric Indicators in Patients With Diabetes Mellitus 2
por: Di Iorio, Adriana Beatriz, et al.
Publicado: (2021)

The Association Between HbA(1c) and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4)
por: Seyed Ahmadi, Shilan, et al.
Publicado: (2020)

Hemoglobin variants detected by hemoglobin A1c (HbA1c) analysis and the effects on HbA1c measurements
por: Nasir, Nadzimah Mohd, et al.
Publicado: (2010)

Measurement of HbA(1c) and HbA(2) by Capillarys 2 Flex Piercing HbA(1c) programme for simultaneous management of diabetes and screening for thalassemia
por: Ke, Peifeng, et al.
Publicado: (2017)

The True Value of HbA1c as a Predictor of Diabetic Complications: Simulations of HbA1c Variables
por: Lind, Marcus, et al.
Publicado: (2009)

Haemoglobin J-Baltimore can be detected by HbA(1c) electropherogram but with underestimated HbA(1c) value
por: Brunel, Valéry, et al.
Publicado: (2016)

MON-118 Reducing Unnecessary Repeat HbA1c Testing in a Tertiary Academic Hospital
por: Rajeswaran, Vamana, et al.
Publicado: (2020)

Influence of Serum Albumin on HbA1c and HbA1c-Defined Glycemic Status: A Retrospective Study
por: Feng, Xiaojing, et al.
Publicado: (2021)

Change in HbA(1c) over 3 years does not improve the prediction of cardiovascular disease over and above HbA(1c) measured at a single time point
por: Chamnan, P., et al.
Publicado: (2013)

Glycated Albumin Correlates With Time-in-Range Better Than HbA(1c) or Fructosamine
por: Desouza, Cyrus V, et al.
Publicado: (2023)

Drugs affecting HbA1c levels
por: Unnikrishnan, Ranjit, et al.
Publicado: (2012)

Current Status of HbA1c Biosensors
por: Lin, Hua, et al.
Publicado: (2017)

Cyclical Variation in HbA(1c) Values During the Year: Clinical and Research Implications
por: Hill, Nathan R., et al.
Publicado: (2013)

Influence of Baseline HbA1c and Antiplatelet Therapy on 1-Year Vein Graft Outcome
por: Zhu, Yunpeng, et al.
Publicado: (2022)

Improved glucometrics in people with type 1 diabetes 1 year into the COVID-19 pandemic
por: Ali, Namam, et al.
Publicado: (2022)

In-House Algorithm for Reporting Discrepant HbA1c Result and Troubleshooting a Case of False Low HbA1c
por: Pant, Vivek, et al.
Publicado: (2021)

Estimation of mean erythrocyte age using HbA1c or HbA1c/glycated albumin for evaluation of anemia severity
por: Koga, Masafumi, et al.
Publicado: (2023)

Factors associated with potential over‐ and undertreatment of hyperglycaemia and annual measurement of HbA(1c) in type 2 diabetes in norwegian general practice
por: Tran, Anh T., et al.
Publicado: (2021)

The Ile191Val Variant of the TAS1R2 Subunit of Sweet Taste Receptors Is Associated With Reduced HbA(1c) in a Human Cohort With Variable Levels of Glucose Homeostasis
por: Serrano, Joan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ciotkevaf68imml8rpov87igo0